Mental health disorders are often overlooked in COPD patients

FHS
March 6, 2025
4:32 pm

Mental health disorders in people with chronic obstructive pulmonary disease (COPD) are underdiagnosed and undertreated, leading to worsened symptoms and decreased quality of life, according to a new study.

Listen: BioMarin’s executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion’s AI bona fides

What does the hiring of a well-known industry dealmaker mean for the future of BioMarin Pharmaceuticals? Can Eli Lilly’s blockbuster obesity medicine lower the risk

August 22, 2024

A Look at Food-Related Illnesses at Restaurants Over the Years

Outbreaks of foodborne illnesses are pretty rare for well-known restaurant chains, but they do happen. This week, an outbreak of Escherichia coli food poisonings linked

October 24, 2024

Madrigal wins first U.S. approval for drug to treat liver disease MASH

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH. The pill, called

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.